These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 19967146)

  • 21. The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy.
    Erduran E; Aksoy A; Zaman D
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):215-7. PubMed ID: 19657319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions.
    Devecioğlu O; Unüvar A; Anak S; Bilge I; Ander H; Ziylan O
    Turk J Pediatr; 2003; 45(1):64-6. PubMed ID: 12718376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies.
    Martin I; Kriaa F; Proulle V; Guillet B; Kaplan C; D'Oiron R; Debré M; Fressinaud E; Laurian Y; Tchernia G; Charpentier B; Lambert T; Dreyfus M
    Br J Haematol; 2002 Dec; 119(4):991-7. PubMed ID: 12472579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative management of Glanzmann's syndrome: how we did it!
    Depner C; Schmid R; Kirchhoff P; Oertli D
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):283-4. PubMed ID: 20182353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Clinicopathological Spectrum, Platelet Glycoprotein IIb/IIIa complex and Platelet Antibodies in Egyptian Children with Glanzmann's Thrombasthenia.
    Zahran AM; Saad K; Elsayh KI; Alblihed MA; Embaby M
    Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):565-571. PubMed ID: 28161816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glanzmann's thrombasthenia in pregnancy: a case and review of the literature.
    Sherer DM; Lerner R
    Am J Perinatol; 1999; 16(6):297-301. PubMed ID: 10586983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different biochemical expression pattern of platelet surface glycoproteins suggests molecular diversity of Glanzmann's thrombasthenia in Iran.
    Farsinejad A; Farajollahi MM; Kazemi A; Saemi N; Faranoush M
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):613-8. PubMed ID: 23912132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
    Di Minno G
    Blood Rev; 2015 Jun; 29 Suppl 1():S26-33. PubMed ID: 26073366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and molecular basis of Glanzmann's thrombasthenia.
    Perutelli P; Mori PG
    Haematologica; 1992; 77(5):421-6. PubMed ID: 1483593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow transplantation for Glanzmann's thrombasthenia.
    Johnson A; Goodall AH; Downie CJ; Vellodi A; Michael DP
    Bone Marrow Transplant; 1994 Jul; 14(1):147-50. PubMed ID: 7951102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
    Hennewig U; Laws HJ; Eisert S; Göbel U
    Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel mutations of integrin αIIb and β3 genes in Turkish children with Glanzmann's thrombasthenia.
    Tokgoz H; Torun Ozkan D; Caliskan U; Akar N
    Platelets; 2015; 26(8):779-82. PubMed ID: 25734216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glanzmann's thrombasthenia and pregnancy.
    Walters JP; Hall JS
    West Indian Med J; 1990 Dec; 39(4):256-8. PubMed ID: 2082573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glanzmann thrombasthenia: integrin alpha IIb beta 3 deficiency.
    Tomiyama Y
    Int J Hematol; 2000 Dec; 72(4):448-54. PubMed ID: 11197210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry.
    Recht M; Rajpurkar M; Chitlur M; d'Oiron R; Zotz R; Di Minno G; Cooper DL; Poon MC
    Am J Hematol; 2017 Jul; 92(7):646-652. PubMed ID: 28370369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
    Fournier DJ; Kabral A; Castaldi PA; Berndt MC
    Thromb Haemost; 1989 Nov; 62(3):977-83. PubMed ID: 2512684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
    Javed A; Ayyub M; Abrar S; Mansoor M; Khan B; Hussain T
    J Ayub Med Coll Abbottabad; 2009; 21(2):171-3. PubMed ID: 20524499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glanzmann's thrombasthenia: identification of 19 new mutations in 30 patients.
    D'Andrea G; Colaizzo D; Vecchione G; Grandone E; Di Minno G; Margaglione M;
    Thromb Haemost; 2002 Jun; 87(6):1034-42. PubMed ID: 12083483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of the GPIIb and GPIIIa genes in patients with Glanzmann's thrombasthenia].
    Yasunaga M; Ryo R; Adachi M; Sugano W; Yoshida A; Nakayama K; Saigo K; Yasunaga K; Yamaguchi N
    Rinsho Ketsueki; 1992 Feb; 33(2):133-8. PubMed ID: 1635160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glanzmann's thrombasthenia proposed optimal management during surgery and delivery.
    Bell JA; Savidge GF
    Clin Appl Thromb Hemost; 2003 Apr; 9(2):167-70. PubMed ID: 12812388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.